Stephen E Kurtz

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Regulatory T Cells

Drug Administration

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Rucha V Modak, Katia Graziella de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E Kurtz, Christopher A Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk, Marina A Gritsenko, Joshua R Hansen, Chelsea Hutchinson, Sara J C Gosline, Paul D Piehowski, Daniel Bottomly, Nicholas James Short, Karin D Rodland, Shannon K McWeeney, Jeffrey W Tyner, Anupriya Agarwal
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Christopher A Eide, Stephen E Kurtz, Andy Kaempf, Nicola Long, Sunil Kumar Joshi, Tamilla Nechiporuk, Ariane Huang, Charles A Dibb, Akosha Taylor, Daniel Bottomly, Shannon K McWeeney, Jessica Minnier, Curtis A Lachowiez, Jennifer N Saultz, Ronan T Swords, Anupriya Agarwal, Bill H Chang, Brian J Druker, Jeffrey W Tyner
Clinical Correlates of Venetoclax-based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy. Blood cancer discovery (2023)
Stephen E Kurtz, Christopher A Eide, Andy Kaempf, Nicola Long, Daniel Bottomly, Olga Nikolova, Brian J Druker, Shannon K McWeeney, Bill H Chang, Jeffrey W Tyner, Anupriya Agarwal
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia. Blood advances 6 (10) (2022)
William G Rice, Stephen B Howell, Hongying Zhang, Nasrin Rastgoo, Andrea Local, Stephen E Kurtz, Pierrette Lo, Daniel Bottomly, Beth Wilmot, Shannon K McWeeney, Brian J Druker, Jeffrey W Tyner
Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia. Molecular cancer therapeutics 21 (7) (2022)
Christopher A Eide, Stephen E Kurtz, Andy Kaempf, Nicola Long, Anupriya Agarwal, Cristina E Tognon, Motomi Mori, Brian J Druker, Bill H Chang, Alexey V Danilov, Jeffrey W Tyner
Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia. Leukemia 34 (9) (2020)
Stephen E Kurtz, Christopher A Eide, Andy Kaempf, Vishesh Khanna, Samantha L Savage, Angela Rofelty, Isabel English, Hibery Ho, Ravi Pandya, William J Bolosky, Hoifung Poon, Michael W Deininger, Robert Collins, Ronan T Swords, Justin Watts, Daniel A Pollyea, Bruno C Medeiros, Elie Traer, Cristina E Tognon, Motomi Mori, Brian J Druker, Jeffrey W Tyner
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies. Proceedings of the National Academy of Sciences of the United States of America 114 (36) (2017)